The Technical Analyst

Olympus Corporation [OCPNY]

Exchange: OTC Sector: Healthcare Industry: Medical Instruments & Supplies

Olympus Corporation Price, Forecast, Insider, Ratings, Fundamentals & Signals

0.00% $18.00

America/New_York / 31 jan 2023 @ 14:34

FIND ALL MARKETS FIND ALL STOCKS LISTED @ OTC Live Signal Oslo Live Signal Nasdaq Live Signal Crypto

Olympus Corporation: Main Fundamentals PE comparison

RATING 2023-03-30
A+
Strong Buy

RATINGS
Rating CashFlow:	Strong Buy
Return On Equity:	Neutral
Return On Asset:	Neutral
DE:	Buy
P/E:	Strong Buy
Price To Book:	Strong Buy

QUARTER GROWTHS
	3/21	4/21	1/22	2/22	3/22	4/22
Revenue
Gr.Profit
Ebit
Asset
Debt

PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 0 \| sector: PE 29.05

PE RATIO: COMPANY / INDUSTRY
N/A
Company: PE 0 \| industry: PE 34.33

DISCOUNTED CASH FLOW VALUE
N/A
N/A

Expected Trading Range (DAY)
$ 17.18 - 18.82 ( +/- 4.55%)
ATR Model: 14 days

Forecast: 01:40 - $17.97

Live Trading Signals (every 1 min)

SCORE
10.00
Buy

Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022

Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD

Volume Signals
Price	$18.00 (0.00% )
Volume	0.0005 mill
Avg. Vol.	0.494 mill
% of Avg. Vol	0.0942 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Olympus Corporation

Last 12 Months

RSI

Intraday RSI14 chart for Olympus Corporation

Last 10 Buy & Sell Signals For OCPNY

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date	Signal	@	Closed	%

OCPNY

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Last 10 Buy Signals

Date	Signal	@
ERNUSD	May 5 - 18:26	$4.47
BTC.BUSD	May 5 - 18:24	63 729
ENSUSD	May 5 - 18:25	15.68
BNBXUSD	May 5 - 18:24	638.71
GALAUSD	May 5 - 18:22	$0.0460
TOMOUSD	May 5 - 18:20	$0.625
SFUNDUSD	May 5 - 18:19	$2.63
NXMUSD	May 5 - 18:15	67.38
AKTUSD	May 5 - 18:20	$4.96
^NZ50	May 5 - 18:00	PTS11 855

Latest Press Releases

2023-11-09 10:25:00 - Press Release

Olympus Corp. Of The Americas To Host Panel Discussion On Lung Cancer Screening Guidelines And Eligibility

Lung cancer awareness month panel will examine who is at risk for lung cancer and what they need to know about the screening process and treatment options center valley, pa. , nov. 9, 2023 /prnewswire/ -- as part of lung cancer awareness month, olympus corp. of the americas (oca) and the american lung association are partnering to raise awareness around the importance of early detection and provide a better understanding of eligibility around lung cancer screening guidelines.

2023-10-27 17:00:00 - Press Release

Olympus Issues Request To Discontinue Use Of Uhi-4 Insufflator Unit, Except In Cases Where No Alternative Is Available

Center valley, pa. , oct. 27, 2023 /prnewswire/ -- olympus corporation has announced a field corrective action in the u.s. to address complaints of adverse events from over insufflation during use of the high-flow insufflation unit uhi-4.

2023-07-03 17:00:00 - Press Release

Olympus Issues Voluntary Labeling Update For Bronchoscopes Used With Laser Therapy Equipment

Center valley, pa. , july 3, 2023 /prnewswire/ -- olympus corporation has announced a voluntary field corrective action to address complaints of endobronchial combustion occurring when laser-compatible bronchoscopes are used during therapeutic procedures in combination with laser therapy equipment or argon plasma coagulation (apc).

Latest News

2023-07-21 14:48:47 - CNBC Television

Healthcare creating more opportunities for tech investors, says Harris Financial's Jamie Cox

Jamie Cox, Harris Financial Group managing partner, joins 'The Exchange' to discuss investment opportunities in medical devices, the intersection of healthcare and technology, and top picks in the medical tech space.

Full Story

2022-11-11 23:45:03 - Seeking Alpha

Olympus Corporation (OCPNY) Q3 2022 Earnings Call Transcript

Olympus Corporation (OTCPK:OCPNY) Q3 2022 Earnings Conference Call November 11, 2022 4:00 AM ET Company Participants Yasuo Takeuchi - President and Chief Executive Officer Chikashi Takeda - Chief Financial Officer Nacho Abia - Chief Operating Officer Stefan Kaufmann - Chief Administrative Officer, Chief Strategy Officer and ESG Officer Yasuo Takeuchi Thank you very much for joining us. I am Takeuchi, CEO.

Full Story

2022-09-06 12:47:15 - Zacks Investment Research

OCPNY or EW: Which Is the Better Value Stock Right Now?

OCPNY vs. EW: Which Stock Is the Better Value Option?

Full Story

2022-08-30 10:32:28 - Zacks Investment Research

What Makes Olympus Corp. (OCPNY) a Good Fit for "Trend Investing"

Olympus Corp. (OCPNY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Full Story

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.